Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer

Author： Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.2, 2013-04, pp. : 251-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite

Hormonal therapy in advanced prostate cancer examined

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients

By Karnon J.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 513-525

Adis International

Access to resources Recommend Favorite

Value of Endocrine Therapy for Early and Locally Advanced Prostate Cancer

By Wirth M.P.   Froehner M.  

Drugs & Aging, Vol. 20, Iss. 2, 2003-01 ,pp. : 115-124

Adis International

Access to resources Recommend Favorite

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

By Roach Mack  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

Blackwell Publishing

Access to resources Recommend Favorite